![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 29, 2018 4:45:48 PM
Nearly 3 years later, they have not started the trials. Have you ever heard of a biopharma getting the green light and not starting trials?
Why?
Could be that the company is insolvent?
Could be they are completely incompetent? ( i personally think not.... he's been cashing $300K every year for a long time )
Could be that the company shelved it as it was only a stock ploy?
or in the words of the well paid CEO:
"We were delighted that our licensees initiated this trial and that Regen could support them. It is gratifying to see that HemaXellerate may have some benefit to these patients," said Dr. David Koos, CEO. Tijuana, Mexico
"MAY HAVE SOME BENEFIT" = They know/knew it doesn't work.
Keep in mind, the entire self-stated premise of RGBP was to protect HemaX from hostile takeovers or make great deals down the road: A TOP PRIORITY.
IMO RGBP was created because BMSN was no longer a viable investable con.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM